Home
>
National Drug Code (NDC)
>
PLETAL
PLETAL - 59148-002-16 - (cilostazol)
Drug Information of PLETAL
| Product NDC: | 59148-002 |
| Proprietary Name: | PLETAL |
| Non Proprietary Name: | cilostazol |
| Active Ingredient(s): | 100 mg/1 & nbsp; cilostazol |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of PLETAL
| Product NDC: | 59148-002 |
| Labeler Name: | Otsuka America Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020863 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990115 |
Package Information of PLETAL
| Package NDC: | 59148-002-16 |
| Package Description: | 60 TABLET in 1 BOTTLE, PLASTIC (59148-002-16) |
NDC Information of PLETAL
| NDC Code | 59148-002-16 |
| Proprietary Name | PLETAL |
| Package Description | 60 TABLET in 1 BOTTLE, PLASTIC (59148-002-16) |
| Product NDC | 59148-002 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | cilostazol |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19990115 |
| Marketing Category Name | NDA |
| Labeler Name | Otsuka America Pharmaceutical, Inc. |
| Substance Name | CILOSTAZOL |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
